GB0213028D0 - Hematology and polymorphism - Google Patents

Hematology and polymorphism

Info

Publication number
GB0213028D0
GB0213028D0 GB0213028A GB0213028A GB0213028D0 GB 0213028 D0 GB0213028 D0 GB 0213028D0 GB 0213028 A GB0213028 A GB 0213028A GB 0213028 A GB0213028 A GB 0213028A GB 0213028 D0 GB0213028 D0 GB 0213028D0
Authority
GB
United Kingdom
Prior art keywords
hematology
polymorphism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0213028A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Priority to GB0213028A priority Critical patent/GB0213028D0/en
Publication of GB0213028D0 publication Critical patent/GB0213028D0/en
Priority to PCT/BE2003/000095 priority patent/WO2003102229A1/en
Priority to AU2003238572A priority patent/AU2003238572A1/en
Ceased legal-status Critical Current

Links

GB0213028A 2002-05-31 2002-06-07 Hematology and polymorphism Ceased GB0213028D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0213028A GB0213028D0 (en) 2002-06-07 2002-06-07 Hematology and polymorphism
PCT/BE2003/000095 WO2003102229A1 (en) 2002-05-31 2003-06-02 HEMATOLOGIC AND RENAL OR CARDIOVASCULAR PHENOTYPES IN RELATION TO THE POLYMORPHISM IN THE β-ADDUCIN GENE
AU2003238572A AU2003238572A1 (en) 2002-05-31 2003-06-02 HEMATOLOGIC AND RENAL OR CARDIOVASCULAR PHENOTYPES IN RELATION TO THE POLYMORPHISM IN THE Beta-ADDUCIN GENE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0213028A GB0213028D0 (en) 2002-06-07 2002-06-07 Hematology and polymorphism

Publications (1)

Publication Number Publication Date
GB0213028D0 true GB0213028D0 (en) 2002-07-17

Family

ID=9938105

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0213028A Ceased GB0213028D0 (en) 2002-05-31 2002-06-07 Hematology and polymorphism

Country Status (1)

Country Link
GB (1) GB0213028D0 (en)

Similar Documents

Publication Publication Date Title
EP1539941A4 (en) Adzymes and uses thereof
ZA200603882B (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides
IL175491A0 (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
AU2003284055A8 (en) Microfluidic systems and components
IL225633A0 (en) Anti-alpha-v-beta - 6 antibodies and uses thereof
EP1551447A4 (en) Anti-addl antibodies and uses thereof
GB0229742D0 (en) Novel compounds and uses thereof
EP1575495A4 (en) Compounds and methods
HK1088837A1 (en) Clk-peptide and slk-peptide
GB0428391D0 (en) Connection and connection part
SI1551805T1 (en) Substituted gamma-phenyl-delta-lactams and uses related thereto
AU2003232075A8 (en) Modified t lymphocytes and uses therefor
GB0202871D0 (en) Assays,methods and means
IL165112A0 (en) Variant integrinpolypeptides and thereof
PL374439A1 (en) Antibodies and uses thereof
GB0221438D0 (en) Processes and compounds
AU2003231827A8 (en) Pseudo-tissues and uses thereof
GB0225750D0 (en) Wiffs away
AU2003302173A8 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
EP1487547A4 (en) Physical interaction means and related uses thereof
GB0213028D0 (en) Hematology and polymorphism
AU2003228397A8 (en) Hausp-p53 interaction and uses thereof
AU2003216442A8 (en) Enkurin and uses thereof
GB0202276D0 (en) Assays
AU2003223357A8 (en) Compounds and methods

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)